Atara Biotherapeutics, Inc.ATRANASDAQ
Loading
EBITDA as a percentage of revenue
Latest
30.86%
↑ 106% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
-510.81%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | 30.86% | +152.5% |
| 2024 | -58.75% | +98.1% |
| 2023 | -3102.73% | -787.5% |
| 2022 | -349.62% | +78.5% |
| 2021 | -1627.91% | - |
| 2020 | 0.00% | - |
| 2019 | 0.00% | - |
| 2018 | 0.00% | - |
| 2017 | 0.00% | - |
| 2016 | 0.00% | - |